publication venue for
- Timely treatment and higher compliance to traditional Chinese medicine: New influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021. 178:106174-106174. 2022
- Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial. 161:105126-105126. 2020
- Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study. 161:105127-105127. 2020
- Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside. 151:104541-104541. 2020
- Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications. 69:42-51. 2013
- Combined action of inhibitors of polyamine biosynthetic pathway with a known antimalarial drug chloroquine on plasmodium falciparum. 31:189-193. 1995